全文获取类型
收费全文 | 6308篇 |
免费 | 296篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 324篇 |
妇产科学 | 193篇 |
基础医学 | 827篇 |
口腔科学 | 241篇 |
临床医学 | 497篇 |
内科学 | 968篇 |
皮肤病学 | 227篇 |
神经病学 | 602篇 |
特种医学 | 220篇 |
外科学 | 960篇 |
综合类 | 129篇 |
一般理论 | 1篇 |
预防医学 | 518篇 |
眼科学 | 123篇 |
药学 | 477篇 |
中国医学 | 38篇 |
肿瘤学 | 195篇 |
出版年
2023年 | 51篇 |
2022年 | 39篇 |
2021年 | 93篇 |
2020年 | 88篇 |
2019年 | 136篇 |
2018年 | 191篇 |
2017年 | 163篇 |
2016年 | 207篇 |
2015年 | 219篇 |
2014年 | 294篇 |
2013年 | 436篇 |
2012年 | 485篇 |
2011年 | 514篇 |
2010年 | 320篇 |
2009年 | 228篇 |
2008年 | 228篇 |
2007年 | 248篇 |
2006年 | 234篇 |
2005年 | 214篇 |
2004年 | 238篇 |
2003年 | 265篇 |
2002年 | 191篇 |
2001年 | 146篇 |
2000年 | 198篇 |
1999年 | 147篇 |
1998年 | 79篇 |
1997年 | 81篇 |
1996年 | 46篇 |
1995年 | 49篇 |
1994年 | 32篇 |
1993年 | 25篇 |
1992年 | 57篇 |
1991年 | 40篇 |
1990年 | 46篇 |
1989年 | 51篇 |
1988年 | 39篇 |
1987年 | 26篇 |
1986年 | 24篇 |
1985年 | 32篇 |
1984年 | 23篇 |
1983年 | 29篇 |
1982年 | 19篇 |
1980年 | 19篇 |
1979年 | 20篇 |
1978年 | 27篇 |
1977年 | 27篇 |
1976年 | 21篇 |
1975年 | 23篇 |
1974年 | 18篇 |
1970年 | 24篇 |
排序方式: 共有6644条查询结果,搜索用时 15 毫秒
1.
Journal of Assisted Reproduction and Genetics - 相似文献
2.
Montagnese Federica Babačić Haris Eichhorn Peter Schoser Benedikt 《Journal of neurology》2019,266(6):1358-1366
Journal of Neurology - Myositis-associated antibodies (MAA) and myositis-specific antibodies (MSA) are detected in patients with idiopathic inflammatory myopathies (IIM); their role as diagnostic... 相似文献
3.
C. Leonardi K. Papp B. Strober D. Thaçi R.B. Warren S. Tyring D. Arikan M. Karunaratne W.C. Valdecantos 《The British journal of dermatology》2019,180(1):76-85
Adalimumab is a powerful drug used to treat psoriasis, that has been specially designed to mimic normal human molecules, and for this reason it is classed as a ‘biological’ drug. It reduces inflammation by inhibiting the activity of a chemical ‘cytokine’ in the body called ‘tumour necrosis factor alpha’ (TNF-alpha). The aim of this study, from the USA, was to assess long-term safety for patients with psoriasis receiving adalimumab. The authors looked at data from 3727 patients receiving the drug as part of 18 different clinical trials in which adverse events (AEs, meaning unwanted side effects while on the drug) were recorded. Overall, there were 16,536 AEs during 5429.7 patient years (304.6 AEs for every 100 patient years). Patient years (PYs) means the number of patients, multiplied by the amount of time they were included in the study. Most common AEs were nasopharyngitis (a common throat complaint), upper respiratory infection, and headache (23.7, 12.9, and 7.9 AEs per 100 PYs, respectively). Incidence rates for serious infections, tuberculosis, and opportunistic infections were 1.8, 0.3, and 0.02 AEs per 100 PYs, respectively. Incidence of malignancy (cancer) excluding non-melanoma skin cancer (NMSC) was 0.8 AEs per 100 PYs. Incidences of NMSC and melanoma were 0.6 and 0.2 AEs per 100 PYs, respectively. The authors conclude that AE rates remained stable in this analysis of patients with psoriasis receiving adalimumab; no new safety signals (such as increased AEs) were identified compared with earlier studies. 相似文献
4.
5.
Diamant Thai Matthias Augustin Jean Krutmann Thomas Luger 《Journal der Deutschen Dermatologischen Gesellschaft》2015,13(5):415-418
Die Basistherapie spielt bei Psoriasis vulgaris eine wichtige Rolle. Dies gilt unabhängig vom Schweregrad der Erkrankung oder dem angewendeten Therapiekonzept. Sie trägt dazu bei, Symptome wie Juckreiz und Schuppenbildung zu vermindern, Exazerbationen zu reduzieren und somit die Remission nach einer erfolgreichen Therapie zu verlängern. Entsprechend kann durch eine adäquate Basistherapie auch die stark beeinträchtigte Lebensqualität von Psoriasis‐Patienten positiv beeinflusst werden. Bedauerlicherweise wird jedoch der Stellenwert einer Basistherapie bei Psoriasis noch immer unterschätzt. Im folgenden Review wird anhand von Studiendaten die Effizienz und das Potenzial der Basistherapie aufgezeigt und auf neue Daten und Entwicklungen in diesem Bereich eingegangen. 相似文献
6.
Psychiatric Quarterly - As a public health emergency, a pandemic increases susceptibility to unfavourable psychological outcomes. The aim of the present study was to investigate the buffering role... 相似文献
7.
Mehmet Ali Kaptan Berat Acu Çiğdem Öztunalı Cüneyt Çalışır Ulukan İnan Muzaffer Bilgin 《Acta orthopaedica et traumatologica turcica》2019,53(4):239-247
ObjectiveThe aim of this prospective study was to evaluate pre- and post-treatment MRI and CT findings of osteoid osteoma (OO) patients treated with radiofrequency thermo-ablation (RFTA) and to compare these findings with visual analog scale (VAS) scores.MethodsSixteen patients (4 females and 12 males; mean age of 18.87 ± 8.75 years (range: 8–37)) with OO were examined with CT and MRI, at baseline and at an average of 3 months following the procedure. On pre- and post-procedural CT and MRIs, OO-related findings were recorded. Treatment success was evaluated with VAS scores.ResultsBaseline VAS scores were 8 or 9 and follow-up scores were 0 or 1, indicating no early recurrences.Nidus diameters decreased significantly after the procedure (p = 0.027, p = 0.002, and p = 0.002; and p = 0.001, p = 0.001, p = 0.001 for AP, ML and CC nidus diameters for CT and MRI, respectively).The mean nidus volume were significantly decreased after the procedure (p = 0.001, for CT and MRI).On post-procedural images, cortical thickening, the signal intensity and contrast enhancement of the nidus and the extent of periostitis were significantly decreased (p = 0.019, p = 0.001, p = 0.001 and p = 0.034, respectively). There was no significant change in nidus calcification, perinidal cortical and intramedullary sclerosis, periosteal reaction, bone deformity, bone marrow and soft tissue edema, joint effusion and synovitis after the procedure (p = 0.253, p = 0.062, p = 0.245, p = 1, p = 1, p = 0.429, p = 0.371, p = 0.625, p = 1).ConclusionAlthough the changes in imaging findings may be helpful in early follow-up of OO patients treated with RFTA, these changes alone cannot be used with accuracy in predicting treatment response.Level of EvidenceLevel IV, Therapeutic Study. 相似文献
8.
9.